Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOMOL Research Laboratories was a prominent life sciences company specializing in the development and supply of high-quality research reagents for the global biomedical research community. Founded in 1983 and headquartered in Plymouth Meeting, Pennsylvania, the company became a leader in signal transduction, apoptosis, lipid research, and protein modification tools. Their product portfolio included a wide array of bioactive lipids, peptides, recombinant proteins, antibodies, and enzyme inhibitors. In 2008, BIOMOL was acquired by Enzo Biochem and integrated into the Enzo Life Sciences division. The company was well-regarded for its Screen-Well compound libraries and specialized assay kits used in drug discovery and basic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOMOL Research Laboratories.